DOI QR코드

DOI QR Code

Helianthus annuus (Sunflower) Seed Oil 의 항염 및 피부 개선 효과 연구

Study on Effect of Skin Soothing by Helianthus annuus (Sunflower) Seed Oil

  • 소지민 ((주)유로핀즈씨알에이) ;
  • 남개원 (서원대학교 바이오코스메틱학과)
  • Jimin So (Eurofins CRA Co., Ltd.) ;
  • Gaewon Nam (Department of Bio-cosmetic Science, Seowon University)
  • 투고 : 2023.10.29
  • 심사 : 2023.12.14
  • 발행 : 2023.12.30

초록

본 연구에서는 Helianthus annuus (Sunflower) seed oil의 in vitro 시험 및 인체적용시험을 통해 항염 효과와 피부 보습, 피지 분비, 피부 장벽기능 개선 및 피부 진정 등 피부 개선 효과를 확인하였다. In vitro 시험 결과, lipopolysaccharide로 염증 반응을 유도한 각질형성세포(cultured human epidermal keratinocytes)에 H. annuus (Sunflower) seed oil을 처리하였을 때 염증성 사이토카인인 IL-6, IL-8, TNF-α가 통계적으로 유의하게 감소하여 항염 효과가 있음을 확인하였다. 또한 H. annuus (Sunflower) seed oil을 함유한 시험제품을 제조하여 민감성 피부 대상으로 4 주간 인체적용시험한 결과, 피부 보습, 피지 분비, 피부 장벽이 개선되었으며, 피부 붉은기와 트러블이 개선되는 등 피부 개선 효과를 확인하였다. 본 연구 결과를 통해 민감성 피부를 타겟으로 한 화장품 원료로서 H. annuus (Sunflower) seed oil의 가능성을 확인하였다.

In this study, in vitro and clinical studies were conducted to assess the anti-inflammatory effects and skin improvement effects, including moisturizing, sebum secretion-regulating, skin barrier function enhancing, and soothing of Helianthus annuus (Sunflower) seed oil. In in vitro study using cultured human epidermal keratinocytes induced with inflammation by lipopolysaccharide, significant decreases in inflammatory cytokines interleukin-6, interleukin-8, and tumor necrosis factor alpha was revealed, indicating the anti-inflammatory effects of H. annuus (Sunflower) seed oil. Additionally, the results of clinical study on subjects with sensitive skin demonstrated improved skin hydration, regulation of sebum secretion, enhanced skin barrier function, as well as amelioration of skin redness and acne, indicating positive effects on overall skin conditions after application of H. annuus (Sunflower) seed oil containing test product for 4 weeks. Results of this study demonstrated the potential of H. annuus (Sunflower) seed oil as an ingredient for cosmetic, targeting consumers with sensitive skin.

키워드

참고문헌

  1. I. Duarte, J. E. P. S. Silveira, M. F. S. Hafner, R. Toyota, and D. M. M. Pedroso, Sensitive skin: review of an ascending concept, An. Bras. Dermatol., 92(4), 521 (2017).
  2. V. Buhe, K. Vie, C. Guere, A. Natalizio, C. Lheritier, C. Le Gall-Ianotto, F. Huet, M. Talagas, N. Lebonvallet, P. Marcorelles, J. L. Carre, and L. Misery, Pathophysiological study of sensitive skin, Acta Derm. Venereol., 96(3), 314 (2016).
  3. K. H. Hanel, C. Cornelissen, B. Luscher, and J. M. Baron, Cytokines and the skin barrier, Int. J. Mol. Sci., 14(4), 6720 (2013).
  4. y.p. Han, T . L. T uan, H. Wu, M. Hughes, and W. L. Garner, TNF-alpha stimulates activation of pro-MMP2 in human skin through NF-(kappa)B mediated induction of MT1-MMP, J. Cell Sci., 114(Pt 1), 131 (2001).
  5. K. T . Lewandowski, R. T hiede, N. Guido, W. L. Daniel, R. Kang, M. I. Guerrero-Zayas, M. A. Seeger, X. Q. Wang, D. A. Giljohann, and A. S. Paller, T opically delivered tumor necrosis factor-α-targeted gene regulation for psoriasis, J. Invest. Dermatol., 137(9), 2027 (2017).
  6. B. Z. Johnson, A. W. Stevenson, C. M. Prele, M. W. Fear, and F. M. Wood, The role of IL-6 in skin fibrosis and cutaneous wound healing, Biomedicines, 8(5), 101 (2020).
  7. T. Amarbayasgalan, H. Takahashi, I. Dekio, and E. Morita, Interleukin-8 content in the stratum corneum as an indicator of the severity of inflammation in the lesions of atopic dermatitis, Int. Arch. Allergy Immunol., 160(1), 63 (2013).
  8. G. Caldarola, C. De Simone, A. Carbone, A. Tulli, P. Amerio, and C. Feliciani, TNFalpha and its receptors in psoriatic skin, before and after treatment with etanercept, Int. J. Immunopathol. Pharmacol., 22(4), 961 (2009).
  9. M. S. Ferreira, J. M. Sousa Lobo, and I. F. Almeida, Sensitive skin: active ingredients on the spotlight, Int. J. Cosmet. Sci., 44(1), 56 (2022).
  10. A. Ratz-Lyko, J. Arct, and K. Pytkowska, Moisturizing and antiinflammatory properties of cosmetic formulations containing Centella asiatica extract, Indian J. Pharm. Sci., 78(1), 27 (2016).
  11. M. S. Ferreira, D. I. S. P. Resende, J. M. S. Lobo, E. Sousa, and I. F. Almeida, Marine ingredients for sensitive skin: market overview, Mar. Drugs, 19(8), 464 (2021).
  12. N. K. Sheikh and A. Dua, Cannabinoids. [Updated 2023 Feb 27]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing (2023-.)
  13. T. Biro, B. I. Toth, G. Hasko, R. Paus, and P. Pacher, The endocannabinoid system of the skin in health and disease: novel perspectives and therapeutic opportunities, Trends Pharmacol. Sci., 30(8), 411 (2009).
  14. M. Maccarrone, M. Di Rienzo, N. Battista, V. Gasperi, P. Guerrieri, A. Rossi, and A. Finazzi-Agro, T he endocannabinoid system in human keratinocytes, J. Biol. Chem., 278, 33896 (2003).
  15. A. Bort, P. A. Alvarado-Vazquez, C. Moracho-Vilrriales, K. G. Virga, G. Gumina, A. Romero-Sandoval, and S. Asbill, Effects of JWH015 in cytokine secretion in primary human keratinocytes and fibroblasts and its suitability for topical/transdermal delivery, Mol. Pain, 13, 1 (2017).
  16. M. Pucci, N. Pasquariello, N. Battista, M. Di Tommaso, C. Rapino, F. Fezza, M. Zuccolo, R. Jourdain, A. Finazzi Agro, and L. Breton, Endocannabinoids stimulate human melanogenesis via type-1 cannabinoid receptor, J. Biol. Chem., 287, 15466 (2012).
  17. N. Dobrosi, B. I. Toth, G. Nagy, A. Dozsa, T. Geczy, L. Nagy, C. C. Zouboulis, R. Paus, L. Kovacs, and T. Biro, Endocannabinoids enhance lipid synthesis and apoptosis of human sebocytes via cannabinoid receptor-2-mediated signaling, FASEB J., 22, 3685 (2008).
  18. E. H. Yoo and J. H. Lee, Cannabinoids and their receptors in skin diseases, Int. J. Mol. Sci., 24(22), 16523 (2023).
  19. T. Biro, B. I. Toth, G. Hasko, R. Paus, and P. Pacher, The endocannabinoid system of the skin in health and disease: novel perspectives and therapeutic opportunities, Trends Pharmacol Sci., 30, 411 (2009).
  20. S. Guo,Y. Ge, and K. Na Jom, A review of phytochemistry, metabolite changes, and medicinal uses of the common sunflower seed and sprouts (Helianthus annuus L.), Chem. Cent. J., 11(1), 95 (2017).
  21. J. G. M. Logger, C. U. Munchhoff, J. I. Olydam, M. Peppelman, and P. E. J. Van Erp, Anatomical site variation of water content in human skin measured by the Epsilon: A pilot study, Skin Res. Technol., 25(3), 333 (2019).
  22. J. M. Crowther, Method for quantification of oils and sebum levels on skin using the Sebumeter(®), Int. J. Cosmet. Sci., 38(2), 210 (2016).
  23. B. E. Kim and D. Y. Leung, Significance of skin barrier dysfunction in atopic dermatitis, Allergy Asthma Immunol. Res., 10(3), 207 (2018).
  24. A. Doshi, A. Zaheer, and M. J. Stiller, A comparison of current acne grading systems and proposal of a novel system, Int. J. Dermatol., 36(6), 416 (1997).
  25. H. C. Lu and K. Mackie, An introduction to the endogenous cannabinoid system, Biol. Psychiatry, 79(7), 516 (2016).
  26. S. Zou and U. Kumar, Cannabinoid receptors and the endocannabinoid system: signaling and function in the central nervous system, Int. J. Mol. Sci., 19(3), 833 (2018).
  27. G. Yucel, Z. Zhao, I. El-Battrawy,H. Lan, S. Lang, X. Li, F. Buljubasic, W. H. Zimmermann, L. Cyganek, J. Utikal,U. Ravens, T. Wieland, M. Borggrefe, X. B. Zhou, and I. Akin, Lipopolysaccharides induced inflammatory responses and electrophysiological dysfunctions in human-induced pluripotent stem cell derived cardiomyocytes, Sci. Rep., 7(1), 2935 (2017).
  28. G. Ikizoglu, Red face revisited: Flushing, 32(6), Clin. Dermatol., 800 (2014).
  29. E. A. Tanghetti, The role of inflammation in the pathology of acne, J. Clin. Aesthet. Dermatol., 6(9), 27 (2013).